Actrims Virtual
MSVirtual2020, September 11-13, 2020 actrims Logo

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

This virtual conference – MSVirtual2020 – involves world class scientists, clinicians and researchers in the field of multiple sclerosis (MS) from around the world presenting the latest research advances, clinical trial data and outcomes, therapeutic advances, new breakthroughs and new cutting-edge technology in MS.

Media registration will allow you to have access to the full program. We hope you will join us for this virtual conference.

#MSVirtual2020

Meeting News Releases on Newswise

Q&A with Leaders of MS Virtual 2020 Conference
ACTRIMS MS Virtual 2020 Q&A with Association Leadership
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 16-Sep-2020 5:10 PM EDT

Primary astrocytopathy has a detrimental effect on remyelination efficacy of parenchymal oligodendrocyte precursor cells

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 9:50 AM EDT

Phase 2 clinical trial evidence that a retinoid-X receptor agonist promotes remyelination in people with relapsing-remitting multiple sclerosis

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 10:05 AM EDT

Neutrophil granulocyte markers in cerebrospinal fluid differentiate NMOSD and anti-MOG antibody associated disease from MS in acute disease phase

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 10:15 AM EDT

Brain microstructural and metabolic alterations detected in vivo at the onset of the first demyelinating event

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 10:30 AM EDT

Network analysis identifies gut bacteria associated with multiple sclerosis relapse among pediatric-onset patients

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 11:05 AM EDT

Interrupting disease modifying treatment for pregnancy in multiple sclerosis – effect on disease activity and serum neurofilament light chain

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 11:15 AM EDT

COVID-19 in people with MS: A large community-based study of the UK MS Register

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 11:40 AM EDT

Comparison of COVID-19 outcomes between racial groups in the COViMS registry

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 12:05 PM EDT

Evidence of an Increased Burden of Humoral Autoimmunity in the CSF and plasma of COVID-19 Patients with Comorbid Neurologic Dysfunction
Coronavirus disease 19 (COVID-19) is the most globally impactful pandemic of the past century.
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 12:10 PM EDT

First results of the COVID-19 in MS Global Data Sharing Initiative suggest anti-CD20 DMTs are associated with worse COVID-19 outcomes

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 12:45 PM EDT

COVID-19 in persons with multiple sclerosis treated with ocrelizumab: pharmacovigilance update

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 12:50 PM EDT

Clinical Characteristics and Outcomes in Patients with Coronavirus Disease 2019 and Multiple Sclerosis

– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 1:05 PM EDT

MEDIA ALERT: MSVirtual2020
The MSVirtual2020 program will continue in an Encore Program that will be held on Saturday, September 26th from 9:00 a.m. – 12:15 p.m. ET. This Encore Program will feature the Late Breaker (9-10:30 a.m. ET) and COVID-19th (10:45 a.m. – 12:15...
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 22-Sep-2020 8:00 AM EDT

Welcome Letter from ACTRIMS President on MSVirtual2020
It is with great pleasure that I welcome you to the 8th joint ACTRIMS-ECTRIMS conference. This conference, MSVirtual2020, is the largest conference dedicated to multiple sclerosis (MS) research and our first virtual conference.
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 11-Sep-2020 6:15 PM EDT

Registered Reporters Are Invited to Three Virtual MSVirtual2020 Press Conferences Featuring: The Latest Clinical Study Outcomes, Advances in Therapeutics, Diagnostics and Technologies, and Late Breakers and COVID-19 Impact on MS Research & Patient Care
The 8th Joint ACTRIMS-ECTRIMS meeting – the largest international conference focused on research in multiple sclerosis (MS), will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News...
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 9-Sep-2020 8:00 AM EDT

The Facts About Multiple Sclerosis
In just the U.S. alone, more than 200 individuals are diagnosed with Multiple Sclerosis (MS) each week. However, when properly managed and controlled with medications and lifestyle adjustments, many of the common MS symptoms like visual and sensory...
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 2-Sep-2020 9:00 AM EDT

The 8th Joint ACTRIMS-ECTRIMS Meeting - MSVirtual2020 - To be Held September 11-13 With A Special Encore Session Featuring COVID-19 & MS and Late Breakers on September 26th
The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a...
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 2-Sep-2020 7:00 AM EDT

Largest International Multiple Sclerosis Research Conference in September 2020
The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on...
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 13-Aug-2020 9:00 AM EDT

Multiple Sclerosis Facts and Figures
Multiple Sclerosis Facts and Figures
– Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) | 13-Aug-2020 9:00 AM EDT

More About MEETING

The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.

This virtual conference – MSVirtual2020 – involves world class scientists, clinicians and researchers in the field of multiple sclerosis (MS) from around the world presenting the latest research advances, clinical trial data and outcomes, therapeutic advances, new breakthroughs and new cutting-edge technology in MS.

Media registration will allow you to have access to the full program including plenary sessions, invited speakers and platform presentations, and industry supported satellite symposia. Registered media will also have access to presentations that you may have missed 24 hours after their live presentations.

Newswise will be the host of the MSVirtual2020 NewsRoom that will provide journalists with information about the conference and its program, press releases, and helpful material, as well as links to the program site. It will also host special press events for media-only, providing journalists with an opportunity to speak with the ACTRIMS and ECTRIMS leaders as well late-breaker investigators in interactive Q&A type session. The press managers will be available to furnish interviews with presenters, clinicians and scientists participating in this conference upon request. You can reach out to them anytime with your requests or questions.

Media Contacts

Lynn Blenkhorn
lynn.blenkhorn@ogilvy.com
(508) 851-0930 (Mobile)

Emily Papp
emily.papp@ogilvy.com
(203) 240-8446 (Mobile)

ACTRIMS

info@msdc2020.org
+ 1 608 310 8960

1818 Parmenter Street, Suite 300
Middleton, Wisconsin 53562
USA

Press Events

  • Opening Press Conference with ACTRIMS and ECTRIMS Leaders with Q&A (Media only)
    -- Friday, September 11th @8:00 a.m. ET
  • Virtual Coffee Break with the ACTRIMS President (Media Only)
    -- Provides you with a chance to ask the President questions regarding key presentations, major conference research themes, studies and clinical outcomes, breakthroughs, current challenges and what’s next in MS research, etc.
    -- Sunday, September 13th @ 7:30 a.m.ET
  • Early Availability of Embargoed Late Breaker Abstracts for Media Only
    -- Thursday Morning, September 24th
  • Late-Breaker Press Event – Q&A with Investigators (Media only)
    -- Friday, September 25th @ 9:00 a.m.ET
  • Encore Event: Late Breaker Presentations (Open to all attendees and media)
    -- Saturday, September 26th at 9-10:30
  • Encore Event: Covid-19 and MS Special Session (For all attendees and media)
    -- Saturday, September 26th @ 10:45-12:15

Program at a Glance

Experts

Gallery

Social Feed